中文名稱: 兔抗MAP2K1/MAP2K2(Phospho-Ser217/Ser221)多克隆抗體
英文名稱: Anti-MAP2K1/MAP2K2(Phospho-Ser217/Ser221) rabbit polyclonal antibody
別 名: ERK activator kinase 1/ERK activator kinase2; MAP kinase kinase 1/MAP kinase kinase 2; MAP2K1/MAP2K1; MAPK/ERK kinase 1/MAPK/ERK kin
相關(guān)類別: 一抗
儲 存: 冷凍(-20℃) 避光
宿 主: Rabbit
抗 原: MAP2K1/MAP2K2(Phospho-Ser217/Ser221)
反應(yīng)種屬: Human, Mouse, Rat
標(biāo) 記 物: Unconjugate
克隆類型: rabbit polyclonal
技術(shù)規(guī)格
Background: |
The protein encoded by this gene is a member of the dual specificity protein kinase family, which acts as a mitogen-activated protein (MAP) kinase kinase. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals. This protein kinase lies upstream of MAP kinases and stimulates the enzymatic activity of MAP kinases upon wide variety of extra- and intracellular signals. As an essential component of MAP kinase signal transduction pathway, this kinase is involved in many cellular processes such as proliferation, differentiation, transcription regulation and development. |
Applications: |
WB, IHC |
Name of antibody: |
MAP2K1/MAP2K2(Phospho-Ser217/Ser221) |
Immunogen: |
Peptide sequence around phosphorylation site of serine 217/221 (I-D-S(p)-M-A) derived from Human MEK1/MEK2. |
Full name: |
mitogen-activated protein kinase kinase 1/2 |
Synonyms: |
CFC3; MEK1; MKK1; MAPKK1; PRKMK1; CFC4; MEK2; MKK2; MAPKK2; PRKMK2 |
SwissProt: |
Q02750/P36507 |
IHC positive control: |
Human breast carcinoma |
IHC Recommend dilution: |
50-100 |
WB Predicted band size: |
45 kDa |
WB Positive control: |
Hela cells treated with UV |
WB Recommended dilution: |
500-1000 |